We are live on ! Find out more
SFM

Sphera Funds Management Portfolio holdings

AUM $630M
1-Year Est. Return 108.65%
This Fund
S&P 500
This Quarter Est. Return
+2.31%
1 Year Est. Return
+108.65%
3 Year Est. Return
+217.64%
5 Year Est. Return
+342.91%
10 Year Est. Return
+2,254.45%
AUM
$720M
AUM Growth
-$214M
Cap. Flow
-$176M
Cap. Flow %
-24.45%
Top 10 Hldgs %
53.82%
Holding
93
New
36
Increased
15
Reduced
13
Closed
19

Top Buys

Rank Stock Value
1
SNY icon
Sanofi
SNY
+$16.4M
2
BIIB icon
Biogen
BIIB
+$11.8M
3
ADBE icon
Adobe
ADBE
+$11M
4
PANW icon
Palo Alto Networks
PANW
+$10.9M
5
KRNT icon
Kornit Digital
KRNT
+$9.29M

Top Sells

Rank Stock Value
1
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$32.5M
2
FIVN icon
FIVE9
FIVN
+$12.8M
3
ALT icon
Altimmune
ALT
+$11.7M
4
NICE icon
Nice
NICE
+$10.9M
5
JNJ icon
Johnson & Johnson
JNJ
+$10.2M

Sector Composition

Rank Sector Weight
1 Healthcare 66.02%
2 Technology 7.17%
3 Industrials 1.19%
4 Consumer Discretionary 1.16%
5 Communication Services 1.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FIVN icon
76
FIVE9
FIVN
$2.11B
– –
-140,968
Closed -$12.8M
FOLD
77
DELISTED
Amicus Therapeutics
FOLD
– –
-753,037
Closed -$8.09M
GNRC icon
78
Generac Holdings
GNRC
$11.6B
– –
-2,310
Closed -$530K
META icon
79
Meta Platforms (Facebook)
META
$1.42T
– –
-50,000
Closed -$8.06M
QQQ icon
80
CALL
Invesco QQQ Trust
QQQ
$453B
– –
-992,800
Closed -$278M
QQQ icon
81
Invesco QQQ Trust
QQQ
$453B
– –
-8,186
Closed -$2.47M
SPY icon
82
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$790B
– –
-199,500
Closed -$75.3M
V icon
83
Visa
V
$684B
– –
-12,600
Closed -$2.48M
VTGN icon
84
CALL
VistaGen Therapeutics
VTGN
$9.89M
– –
-50,000
Closed -$1.32M
VTGN icon
85
VistaGen Therapeutics
VTGN
$9.89M
– –
-109,705
Closed -$2.9M
XBI icon
86
CALL
State Street SPDR S&P Biotech ETF
XBI
$9.95B
– –
-200,000
Closed -$14.9M
XBI icon
87
State Street SPDR S&P Biotech ETF
XBI
$9.95B
– –
-437,748
Closed -$32.5M
VINC
88
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
– –
-3,523
Closed -$93K
KNTE
89
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
– –
-91,673
Closed -$1.16M
ISEE
90
CALL
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
– –
-200,000
Closed -$1.92M
1 2 3
4

Similar funds

VIM
Vancity Investment Management Vancouver, British Columbia, Canada $629M AUM 2.49% 1-Year Est. Return
KCMH
Keywise Capital Management (HK) Hong Kong $630M AUM 81.01% 1-Year Est. Return
FCFC
First Commonwealth Financial Corp Indiana, Pennsylvania $629M AUM 20.47% 1-Year Est. Return
BI
BlueSpruce Investments Chicago, Illinois $631M AUM 11.83% 1-Year Est. Return
PWW
Pettyjohn Wood & White Lynchburg, Virginia $628M AUM 20.96% 1-Year Est. Return
TTSTC
Texas Treasury Safekeeping Trust Company Austin, Texas $628M AUM 15.58% 1-Year Est. Return
SWP
Summit Wealth Partners Orlando, Florida $632M AUM 9.71% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Sphera Funds Management's Q3 2022 Portfolio in Review

As of Q3 2022, Sphera Funds Management held 93 positions worth $720M, down 23% from $935M the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Sphera Funds Management withdrew a net $176M in Q3 2022, closing 19 positions and reducing 13 holdings. Its most notable exit was State Street SPDR S&P Biotech ETF, an estimated $32.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 66% of assets, up from 47% a quarter earlier, followed by Technology and Industrials.

Against the trend, Sphera Funds Management opened a new position in Biogen worth $14.8M.

  • Sphera Funds Management's largest Q3 2022 buy was Biogen: 55,500 shares worth $14.8M.
  • Sphera Funds Management added most to Sanofi in Q3 2022, an estimated $16.4M increase.
  • Sphera Funds Management's biggest Q3 2022 reduction was Altimmune, cutting an estimated $11.7M.
  • Sphera Funds Management fully exited State Street SPDR S&P Biotech ETF in Q3 2022, selling an estimated $32.5M.
  • Sphera Funds Management's ten largest holdings make up 54% of its $720M portfolio in Q3 2022.
  • Sphera Funds Management opened 36 new positions and closed 19 in Q3 2022.
  • Sphera Funds Management's portfolio value fell 23% quarter-over-quarter to $720M.

Based on Sphera Funds Management's 13F filing for Q3 2022, filed 14 Nov 2022.